Estimate cumulative anticholinergic and sedative medication burden using the Drug Burden Index (DBI) formula. Enter each medication's current daily dose and minimum effective daily dose.
where D = daily dose and δ = minimum effective daily dose.
Total DBI = sum of all included medicine contributions.
This tool is educational and does not replace professional medical review. Always confirm dose values and interpretation with a clinician or pharmacist.
What is the Drug Burden Index?
The Drug Burden Index (DBI) is a medication risk metric used to estimate a person's cumulative exposure to medicines with anticholinergic and sedative effects. These effects are especially important in older adults, where higher medication burden may be associated with reduced physical function, reduced cognitive performance, daytime drowsiness, and increased fall risk.
DBI is not a diagnosis and not a stand-alone treatment decision tool. It is a structured way to support medication review during discussions between patients, prescribers, and pharmacists.
How the calculator works
Inputs you need
- Medication name: For your own tracking in the output table.
- Daily dose (D): The dose currently taken per day.
- Minimum effective daily dose (δ): A reference value from trusted prescribing resources.
- Include checkbox: Use this to temporarily include/exclude a medicine.
Calculation logic
For each medication, this page calculates:
Contribution = D / (δ + D)
A medicine taken at dose zero contributes 0. As dose rises, the contribution approaches 1 (but does not exceed it). The calculator then sums all contributions to produce total DBI.
Interpreting DBI scores
Interpretation should always be individualized. In general, higher DBI implies higher cumulative pharmacologic burden.
- 0: No measurable burden from entered medicines.
- >0 to <1: Lower cumulative burden.
- 1 to <2: Moderate cumulative burden.
- 2+: Higher cumulative burden, often worth a careful medication review.
These cut points are practical categories, not strict clinical rules. Clinical context is everything: age, frailty, kidney and liver function, cognition, falls history, and treatment goals all matter.
Why DBI matters in polypharmacy
Polypharmacy can be necessary and appropriate, but as medication count increases, so does complexity. DBI helps teams focus not just on the number of medicines, but on specific pharmacologic burden from sedative and anticholinergic load.
- Supports structured deprescribing conversations.
- Helps prioritize candidates for dose reduction.
- Improves communication across transitions of care.
- Provides a reproducible baseline for follow-up comparisons.
Best practices when using this tool
1) Verify dose accuracy
Confirm total daily dose from medication labels and directions. Include regular doses and clinically relevant scheduled doses.
2) Use reliable minimum dose references
The minimum effective daily dose should come from authoritative clinical references, local formularies, or specialist guidance. Using inconsistent references can change calculated DBI.
3) Recalculate after changes
DBI is dynamic. Repeat the calculation whenever medications are started, stopped, or dose-adjusted.
Limitations to understand
- DBI does not capture every adverse effect pathway.
- It does not replace patient-specific clinical assessment.
- Different regions may use different minimum dose references.
- Some medicines have mixed mechanisms and nuanced effects not fully represented by a single score.
Frequently asked questions
Is a high DBI always bad?
Not always. Some patients need higher-burden regimens for symptom control. A high DBI is a flag for review, not an automatic mandate to stop therapy.
Can DBI be used in younger adults?
It can be calculated, but it is most often used in older populations where functional and cognitive vulnerability may be greater.
Should I stop medicine based on this calculator?
No. Never stop or reduce prescription medicines without clinician guidance. Use this result to start an informed, shared decision-making conversation.